115
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Eutectic solutions for healing: a comprehensive review on therapeutic deep eutectic solvents (TheDES)

ORCID Icon & ORCID Icon
Pages 387-400 | Received 29 Feb 2024, Accepted 15 Apr 2024, Published online: 24 Apr 2024

References

  • Amidon GL, Lennernäs H, Shah VP, et al. Biopharmaceutic drug classification. Pharm Res. 1995;12(3):413–420. doi: 10.1023/A:1016212804288.
  • Smith EL, Abbott AP, Ryder KS. Deep eutectic solvents (DESs) and their applications. Chem Rev. 2014;114(21):11060–11082. doi: 10.1021/cr300162p.
  • Abbott AP, Capper G, Davies DL, et al. Preparation of novel, moisture-stable, Lewis-acidic ionic liquids containing quaternary ammonium salts with functional side chains. Chem Commun (Camb). 2001;1(19):2010–2011. doi: 10.1039/b106357j.
  • Zhang Q, De Oliveira Vigier K, Royer S, et al. Deep eutectic solvents: syntheses, properties and applications. Chem Soc Rev. 2012;41(21):7108–7146. doi: 10.1039/c2cs35178a.
  • Oyoun F, Toncheva A, Henríquez LC, et al. Deep eutectic solvents: an eco-friendly design for drug engineering. ChemSusChem. 2023;16(20):e202300669. doi: 10.1002/cssc.202300669.
  • Tomé LIN, Baião V, da Silva W, et al. Deep eutectic solvents for the production and application of new materials. Appl Mater Today. 2018;10:30–50. doi: 10.1016/j.apmt.2017.11.005.
  • Roda A, Matias A, Paiva A, et al. Polymer science and engineering using deep eutectic solvents. Polymers. 2019;11(5):912. doi: 10.3390/polym11050912.
  • Farooq MQ, Abbasi NM, Anderson JL. Deep eutectic solvents in separations: methods of preparation, polarity, and applications in extractions and capillary electrochromatography. J Chromatogr A. 2020;1633:461613. doi: 10.1016/j.chroma.2020.461613.
  • Sekiguchi K, Obi N. Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull. 1961;9(11):866–872. doi: 10.1248/cpb.9.866.
  • Stott PW, Williams AC, Barry BW. Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J Control Release. 1998;50(1–3):297–308.
  • Stott PW, Williams AC, Barry BW. Mechanistic study into the enhanced transdermal permeation of a model b-blocker, propranolol, by fatty acids: a melting point depression effect. 2001. Available from www.elsevier.com/locate/ijpharm.
  • Bica K, Shamshina J, Hough WL, et al. Liquid forms of pharmaceutical co-crystals: exploring the boundaries of salt formation. Chem Commun (Camb). 2011;47(8):2267–2269. doi: 10.1039/c0cc04485g.
  • Silva JM, Pereira CV, Mano F, et al. Therapeutic role of deep eutectic solvents based on menthol and saturated fatty acids on wound healing. ACS Appl Bio Mater. 2019;2(10):4346–4355. doi: 10.1021/acsabm.9b00598.
  • Wang H, Gurau G, Shamshina J, et al. Simultaneous membrane transport of two active pharmaceutical ingredients by charge assisted hydrogen bond complex formation. Chem. 2014;5(9):3449. doi: 10.1039/C4SC01036A.
  • Gala U, Chuong MC, Varanasi R, et al. Characterization and comparison of lidocaine-tetracaine and lidocaine-camphor eutectic mixtures based on their crystallization and hydrogen-bonding abilities. AAPS PharmSciTech. 2015;16(3):528–536. doi: 10.1208/s12249-014-0242-4.
  • Li L, Cai B, Li H, et al. Dermal effects and pharmacokinetic evaluation of the lidocaine/prilocaine cream in healthy chinese volunteers. BMC Pharmacol Toxicol. 2023;24(1):51. doi: 10.1186/s40360-023-00690-x.
  • Park C-W, Mansour HM, Oh T-O, et al. Phase behavior of itraconazole-phenol mixtures and its pharmaceutical applications. Int J Pharm. 2012;436(1–2):652–658. doi: 10.1016/j.ijpharm.2012.07.054.
  • Abbott AP, Ahmed EI, Prasad K, et al. Liquid pharmaceuticals formulation by eutectic formation. Fluid Phase Equilib. 2017;448:2–8. doi: 10.1016/j.fluid.2017.05.009.
  • Saha M, Saha M, Rahman MS, et al. Molecular and spectroscopic insights of a choline chloride based therapeutic deep eutectic solvent. J Phys Chem A. 2020;124(23):4690–4699. doi: 10.1021/acs.jpca.0c00851.
  • Kaplun-Frischoff Y, Touitou E. Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. J Pharm Sci. 1997;86(12):1394–1399.
  • Woolfson AD, Malcolm RK, Campbell K, et al. Rheological, mechanical and membrane penetration properties of novel dual drug systems for percutaneous delivery. J Control Release. 2000;67(2-3):395–408. doi: 10.1016/S0168-3659(00)00230-3.
  • Aroso IM, Craveiro R, Rocha Â, et al. Design of controlled release systems for THEDES - therapeutic deep eutectic solvents, using supercritical fluid technology. Int J Pharm. 2015;492(1–2):73–79. doi: 10.1016/j.ijpharm.2015.06.038.
  • Corvis Y, Négrier P, Lazerges M, et al. Lidocaine/l-menthol binary system: cocrystallization versus solid-State immiscibility. J Phys Chem B. 2010;114(16):5420–5426. doi: 10.1021/jp101303j.
  • Yin T, Wu J, Yuan J, et al. Therapeutic deep eutectic solvent based on osthole and paeonol: preparation, characterization, and permeation behavior. J Mol Liq. 2022;346:117133. doi: 10.1016/j.molliq.2021.117133.
  • Cordeiro T, Castiñeira C, Mendes D, et al. Stabilizing unstable amorphous menthol through inclusion in mesoporous silica hosts. Mol Pharm. 2017;14(9):3164–3177. doi: 10.1021/acs.molpharmaceut.7b00386.
  • Al-Akayleh F, Mohammed Ali HH, Ghareeb MM, et al. Therapeutic deep eutectic system of capric acid and menthol: characterization and pharmaceutical application. J Drug Deliv Sci Technol. 2019;53:101159. doi: 10.1016/j.jddst.2019.101159.
  • Aroso IM, Silva JC, Mano F, et al. Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems. Eur J Pharm Biopharm. 2016;98:57–66. doi: 10.1016/j.ejpb.2015.11.002.
  • Mano F, Martins M, Sá-Nogueira I, et al. Production of electrospun fast-dissolving drug delivery systems with therapeutic eutectic systems encapsulated in gelatin. AAPS PharmSciTech. 2017;18(7):2579–2585. doi: 10.1208/s12249-016-0703-z.
  • Lodzki M, Godin B, Rakou L, et al. Cannabidiol—transdermal delivery and anti-inflammatory effect in a murine model. J Control Release. 2003;93(3):377–387. doi: 10.1016/j.jconrel.2003.09.001.
  • Shen Q, Li X, Li W, et al. Enhanced intestinal absorption of daidzein by borneol/menthol eutectic mixture and microemulsion. AAPS PharmSciTech. 2011;12(4):1044–1049. doi: 10.1208/s12249-011-9672-4.
  • Morrison HG, Sun CC, Neervannan S. Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles. Int J Pharm. 2009;378(1–2):136–139. doi: 10.1016/j.ijpharm.2009.05.039.
  • Marques Silva JM, Reis RL, Paiva A, et al. Design of functional therapeutic deep eutectic solvents based on choline chloride and ascorbic acid. 2018. Available from http://pubs.acs.org.
  • Jeliński T, Przybyłek M, Cysewski P. Natural deep eutectic solvents as agents for improving solubility, stability and delivery of curcumin. Pharm Res. 2019;36(8):116. doi: 10.1007/s11095-019-2643-2.
  • Zainal-Abidin MH, Hayyan M, Ngoh GC, et al. Doxorubicin loading on functional graphene as a promising nanocarrier using ternary deep eutectic solvent systems. ACS Omega. 2020;5(3):1656–1668. doi: 10.1021/acsomega.9b03709.
  • Oliveira F, Silva E, Matias A, et al. Menthol-based deep eutectic systems as antimicrobial and anti-inflammatory agents for wound healing. Eur J Pharm Sci. 2023;182:106368. doi: 10.1016/j.ejps.2022.106368.
  • Akbar N, Khan NA, Ibrahim T, et al. Antimicrobial activity of novel deep eutectic solvents. Pharm. 2023;91(1):9. doi: 10.3390/scipharm91010009.
  • Silva JM, Silva E, Reis RL, et al. A closer look in the antimicrobial properties of deep eutectic solvents based on fatty acids. Sustain Chem Pharm. 2019;14:100192. doi: 10.1016/j.scp.2019.100192.
  • Zakrewsky M, Banerjee A, Apte S, et al. Choline and geranate deep eutectic solvent as a broad-spectrum antiseptic agent for preventive and therapeutic applications. Adv Healthc Mater. 2016;5(11):1282–1289. doi: 10.1002/adhm.201600086.
  • Mao S, Li K, Hou Y, et al. Synergistic effects of components in deep eutectic solvents relieve toxicity and improve the performance of steroid biotransformation catalyzed by Arthrobacter simplex. J Chem Tech Biotech. 2018;93(9):2729–2736. doi: 10.1002/jctb.5629.
  • Mouffok A, Bellouche D, Debbous I, et al. Synergy of garlic extract and deep eutectic solvents as promising natural antibiotics: experimental and COSMO-RS. J Mol Liq. 2023;375:121321. doi: 10.1016/j.molliq.2023.121321.
  • Rodríguez-Juan E, López S, Abia R, et al. Antimicrobial activity on phytopathogenic bacteria and yeast, cytotoxicity and solubilizing capacity of deep eutectic solvents. J Mol Liq. 2021;337:116343. doi: 10.1016/j.molliq.2021.116343.
  • Zhao B-Y, Xu P, Yang F-X, et al. Biocompatible deep eutectic solvents based on choline chloride: characterization and application to the extraction of rutin from Sophora japonica. ACS Sustainable Chem. 2015;3(11):2746–2755. doi: 10.1021/acssuschemeng.5b00619.
  • Syed UT, Leonardo I, Lahoz R, et al. Microengineered membranes for sustainable production of hydrophobic deep eutectic solvent-based nanoemulsions by membrane emulsification for enhanced antimicrobial activity. ACS Sustainable Chem. 2020;8(44):16526–16536. doi: 10.1021/acssuschemeng.0c05612.
  • Wojeicchowski JP, Marques C, Igarashi-Mafra L, et al. Extraction of phenolic compounds from rosemary using choline chloride – based deep eutectic solvents. Sep Purif Technol. 2021;258:117975. doi: 10.1016/j.seppur.2020.117975.
  • Radošević K, Čanak I, Panić M, et al. Antimicrobial, cytotoxic and antioxidative evaluation of natural deep eutectic solvents. Environ Sci Pollut Res Int. 2018;25(14):14188–14196. doi: 10.1007/s11356-018-1669-z.
  • Marei HF, Arafa MF, Essa EA, et al. Lidocaine as eutectic forming drug for enhanced transdermal delivery of nonsteroidal anti-inflammatory drugs. J Drug Deliv Sci Technol. 2021;61:102338. doi: 10.1016/j.jddst.2021.102338.
  • Shomaker TS, Zhang J, Love G, et al. Evaluating skin anesthesia after administration of a local anesthetic system consisting of an S-CaineTM patch and a controlled heat-aided drug delivery (CHADDTM) patch in volunteers. Clin J Pain. 2000;16(3):200–204. doi: 10.1097/00002508-200009000-00004.
  • Curry SE, Finkel JC. Use of the SyneraTM patch for local anesthesia before vascular access procedures: a randomized, double-blind, placebo-controlled study. Pain Med. 2007;8(6):497–502. doi: 10.1111/j.1526-4637.2006.00204.x.
  • Porst H, Burri A. FortacinTM spray for the treatment of premature ejaculation. Urologia J. 2017;84(2_suppl):1–10. doi: 10.5301/uj.5000275.
  • Mir B, Bakhtawar, Naz S, Uroos M, Ali B, Sharif F. Pharmaceutical applications of lidocaine-based ionic liquids – a remarkable innovation in drug delivery. J Mol Liq. 2024;397:124052. doi: 10.1016/j.molliq.2024.124052.
  • Benito C, Atilhan M, Aparicio S. Liquid formulations of local anesthetics through deep eutectics based on monoterpenoids. J Mol Liq. 2023;369:120852. doi: 10.1016/j.molliq.2022.120852.
  • Zainal-Abidin MH, Hayyan M, Ngoh GC, et al. Potentiating the anti-cancer profile of tamoxifen-loaded graphene using deep eutectic solvents as functionalizing agents. Appl Nanosci. 2020;10(1):293–304. doi: 10.1007/s13204-019-01105-2.
  • Pereira CV, Silva JM, Rodrigues L, et al. Unveil the anticancer potential of limomene based therapeutic deep eutectic solvents. Sci Rep. 2019;9(1):14926. doi: 10.1038/s41598-019-51472-7.
  • Pradeepkumar P, Subbiah A, Rajan M. Synthesis of bio-degradable poly(2-hydroxyethyl methacrylate) using natural deep eutectic solvents for sustainable cancer drug delivery. SN Appl. 2019;1(6):568. doi: 10.1007/s42452-019-0591-4.
  • Pradeepkumar P, Rajan M, Almoallim HS, et al. Targeted delivery of doxorubicin in HeLa cells using self-assembled polymeric nanocarriers guided by deep eutectic solvents. ChemistrySelect. 2021;6(28):7232–7241. doi: 10.1002/slct.202000036.
  • Mbous YP, Hayyan M, Wong WF, et al. Simulation of deep eutectic solvents’ interaction with membranes of cancer cells using COSMO-RS. J Phys Chem B. 2020;124(41):9086–9094. doi: 10.1021/acs.jpcb.0c04801.
  • Sun X, Pradeepkumar P, Rajendran NK, et al. Natural deep eutectic solvent supported targeted solid-liquid polymer carrier for breast cancer therapy. RSC Adv. 2020;10(61):36989–37004. doi: 10.1039/d0ra03790g.
  • Global tuberculosis report 2023. 2023. Available from https://iris.who.int/.
  • Becker C, Dressman JB, Junginger HE, et al. Biowaiver monographs for immediate release solid oral dosage forms: rifampicin. J Pharm Sci. 2009;98(7):2252–2267. doi: 10.1002/jps.21624.
  • Rajbongshi T, Sarmah KK, Sarkar A, et al. Preparation of pyrazinamide eutectics versus cocrystals based on supramolecular synthon variations. Cryst Growth Des. 2018;18(11):6640–6651. doi: 10.1021/acs.cgd.8b00878.
  • Santos F, Leitão MPS, Duarte AC. Properties of therapeutic deep eutectic solvents of l-arginine and ethambutol for tuberculosis treatment. Molecules. 2018;24(1):55. doi: 10.3390/molecules24010055.
  • Roda A, Santos F, Matias AA, et al. Design and processing of drug delivery formulations of therapeutic deep eutectic systems for tuberculosis. J Supercrit Fluids. 2020;161:104826. doi: 10.1016/j.supflu.2020.104826.
  • Kharroubi AT, Darwish HM. Diabetes mellitus: the epidemic of the century. World J Diabetes. 2015;6(6):850–867. doi: 10.4239/wjd.v6.i6.850.
  • Wu D, Hu D, Chen H, et al. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer. Nature. 2018;559(7715):637–641. doi: 10.1038/s41586-018-0350-5.
  • Gradel AKJ, Porsgaard T, Lykkesfeldt J, et al. Subcutaneous administration of insulin is associated with regional differences in injection depot variability and kinetics in the rat. Exp Clin Endocrinol Diabetes. 2020;128(5):332–338. doi: 10.1055/a-0658-1089.
  • Li Y, Wu X, Zhu Q, et al. Improving the hypoglycemic effect of insulin via the nasal administration of deep eutectic solvents. Int J Pharm. 2019;569:118584. doi: 10.1016/j.ijpharm.2019.118584.
  • Vaidya A, Mitragotri S. Ionic liquid-mediated delivery of insulin to buccal mucosa. J Control Release. 2020;327:26–34. doi: 10.1016/j.jconrel.2020.07.037.
  • Tanner EEL, Ibsen KN, Mitragotri S. Transdermal insulin delivery using choline-based ionic liquids (CAGE). J Control Release. 2018;286:137–144. doi: 10.1016/j.jconrel.2018.07.029.
  • Banerjee A, Ibsen K, Iwao Y, et al. Transdermal protein delivery using choline and geranate (CAGE) deep eutectic solvent. Adv Healthc Mater. 2017;6(15):1601411. doi: 10.1002/adhm.201601411.
  • Flora GD, Nayak MK. A brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr Pharm Des. 2019;25(38):4063–4084. doi: 10.2174/1381612825666190925163827.
  • Li W, Wang L, Huang W, et al. Inhibition of ROS and inflammation by an imidazopyridine derivative X22 attenuate high fat diet-induced arterial injuries. Vascul Pharmacol. 2015;72:153–162. doi: 10.1016/j.vph.2015.05.006.
  • Wikene KO, Bruzell E, Tønnesen HH. Characterization and antimicrobial phototoxicity of curcumin dissolved in natural deep eutectic solvents. Eur J Pharm Sci. 2015;80:26–32. doi: 10.1016/j.ejps.2015.09.013.
  • Abbasi NM, Farooq MQ, Anderson JL. Investigating the effect of systematically modifying the molar ratio of hydrogen bond donor and acceptor on solvation characteristics of deep eutectic solvents formed using choline chloride salt and polyalcohols. J Chromatogr A. 2022;1667:462871. doi: 10.1016/j.chroma.2022.462871.
  • Ijardar SP, Singh V, Gardas RL. Revisiting the physicochemical properties and applications of deep eutectic solvents. Molecules. 2022;27(4):1368. doi: 10.3390/molecules27041368.
  • Duarte ARC, Ferreira ASD, Barreiros S, et al. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: solubility and permeability studies. Eur J Pharm Biopharm. 2017;114:296–304. doi: 10.1016/j.ejpb.2017.02.003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.